Guilin Sanjin recently stated at an online exchange meeting that Sanjin granular products are the company's current focus on cultivating. Although sales have increased rapidly, due to the small scale of current revenue, their contribution to the company's overall sales volume has not yet been highlighted, and it will still take some time to achieve scale growth. In the future, the company will accelerate the sales progress of Sanjin granules in hospitals and strive to achieve an early increase in scale.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.